| Serial Number | 79387958 |
| Word Mark | RIBORENOSTAR |
| Filing Date | Friday, November 10, 2023 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, January 28, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 28, 2025 |
| Goods and Services | Medicines for humans for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; crude drugs being pharmaceutical preparations for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; pharmaceutical preparations for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; chemico-pharmaceutical preparations for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; biological preparations for medical purposes for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; chemical preparations for pharmaceutical purposes for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; chemical preparations for medical purposes for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; drugs for medical purposes, namely, pharmaceutical preparations for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; diagnostic preparations for medical purposes; potassium salts for medical purposes; sodium salts for medical purposes; pharmaceuticals for the treatment of cancer; anti-cancer preparations; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the prevention and treatment of cancer; tumor suppressing agents; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the central nervous system; pharmaceuticals for the treatment of infectious diseases; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; anticoagulants; cardiovascular pharmaceuticals; pharmaceutical preparations for ocular or intraocular surgery; dietetic food and beverages adapted for medical use; depuratives for the body; medicines for veterinary purposes, namely, veterinary preparations for the treatment and diagnosis of gastrointestinal diseases, cardiovascular diseases, metabolic diseases, and liver diseases; pesticides; dressings, medical; composite materials for dental purposes; diapers for pets |
| Pseudo Mark | RIBO RENO STAR |
| Goods and Services | Technological research in the field of pharmaceutical manufacturing processes and pharmaceutical studies; development of pharmaceutical preparations and medicines; pharmaceutical product evaluation; pharmaceutical research and development services; research in the field of pharmaceuticals; scientific research; chemical research and analysis; development and testing of chemical production methods; biochemical research and analysis; scientific research in the nature of conducting clinical trials for others; medical research; testing of pharmaceuticals; industrial design |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 26, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 26, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Suzhou Ribo Life Science Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | CN |
| Party Name | Suzhou Ribo Life Science Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | CN |
| Event Date | Event Description |
| Tuesday, June 18, 2024 | ASSIGNED TO EXAMINER |
| Thursday, June 20, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, June 21, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, July 11, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, July 11, 2024 | REFUSAL PROCESSED BY MPU |
| Thursday, January 25, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, January 26, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, January 30, 2024 | APPLICATION FILING RECEIPT MAILED |
| Monday, December 30, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, December 30, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, December 30, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, January 2, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, January 2, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, January 2, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, January 2, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, January 2, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, January 22, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 28, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 28, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Sunday, July 28, 2024 | REFUSAL PROCESSED BY IB |